Dermal and Transdermal Drug Delivery Systems

Dear Colleagues,

Over time, research has focused on developing new strategies to improve the bioavailability of topical therapies and increase their efficiency while minimizing adverse events. As a result, there has been a growing interest in transdermal and dermal drug delivery systems. These versatile systems allow active pharmaceutical components to penetrate the stratum corneum and to be involved in local or systemic actions. The use of dermal and transdermal drug delivery systems is accompanied by several advantages such as being noninvasive, less painful, controlling the drug release rate over a prolonged period, not involving the passage through the gastrointestinal tract, and therefore avoidance of first-pass metabolism, without pH, enzymes and intestinal bacteria interferences. Significantly progress has been made in the delivery of various agents in a wide spectrum of symptoms and pathologies, including pain management, hormonal therapies, and cardiovascular and central nervous system diseases.

As an editorial team with clinical and research experience in novel therapies (drug delivery systems, nanotechnology, bioactive materials, transdermal drug delivery systems, biologic therapy, immunotherapy), we are pleased to invite you to contribute your recent work to this Special Issue, which aims to bring together the most innovative and interesting advances made in the dermal and transdermal drug delivery systems.

Original research articles and review papers focusing on this intriguing field are welcome to be considered for publication in this Special Issue. We look forward to receiving your contributions.

Dr. Mara Mădălina Mihai
Dr. Olguta Anca Orzan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• transdermal drug delivery
• dermal drug delivery
• nanotechnology
• biopatch
• nanocarriers
• microneedles
• skin penetration
• electroporation
• iontophoresis